Provided by Tiger Trade Technology Pte. Ltd.

United Therapeutics

485.36
+6.431.34%
Post-market: 485.360.00000.00%17:36 EST
Volume:297.15K
Turnover:144.50M
Market Cap:20.90B
PE:18.40
High:489.50
Open:483.81
Low:481.95
Close:478.93
52wk High:519.99
52wk Low:266.98
Shares:43.06M
Float Shares:41.99M
Volume Ratio:0.77
T/O Rate:0.71%
Dividend:- -
Dividend Rate:- -
EPS(TTM):26.38
EPS(LYR):24.64
ROE:20.04%
ROA:13.14%
PB:3.17
PE(LYR):19.70

Loading ...

Assessing United Therapeutics (UTHR) Valuation After Positive MiroliverELAP Phase 1 Safety And Survival Data

Simply Wall St.
·
Feb 06

United Therapeutics EVP & General Counsel Paul A. Mahon Reports Disposal of Common Shares

Reuters
·
Feb 06

United Therapeutics Director Jan Malcolm Reports Sale of Common Shares

Reuters
·
Feb 04

United Therapeutics President and COO Michael Benkowitz Reports Disposal of Common Shares

Reuters
·
Feb 04

United Therapeutics President and COO Michael Benkowitz Reports Disposal of Common Shares

Reuters
·
Jan 29

United Therapeutics Says Its Experimental Liver Assist Device Met Primary Goal in Phase 1 Study

MT Newswires Live
·
Jan 26

BRIEF-United Therapeutics Announces Positive Results From Phase 1 Study Of Miroliverelap In Patients With Acute Liver Failure

Reuters
·
Jan 26

United Therapeutics Announces Positive Results From Phase 1 Study of Miroliverelap® in Patients With Acute Liver Failure

THOMSON REUTERS
·
Jan 26

United Therapeutics Corp - Study Met Primary Endpoint of Survival During Treatment

THOMSON REUTERS
·
Jan 26

United Therapeutics Corp - No Unexpected Serious Adverse Events Reported

THOMSON REUTERS
·
Jan 26

Assessing United Therapeutics (UTHR) Valuation After Recent Share Price Swings

Simply Wall St.
·
Jan 25

United Therapeutics Corporation Files Initial Statement of Beneficial Ownership for Director Kevin Tracey

Reuters
·
Jan 24

United Therapeutics appoints new director, updates bylaws

TIPRANKS
·
Jan 23

United Therapeutics Appoints Kevin J. Tracey to Board of Directors

Reuters
·
Jan 22

United Therapeutics Corporation Announces Appointment of Kevin J. Tracey to Its Board of Directors

THOMSON REUTERS
·
Jan 22

United Therapeutics Director Jan Malcolm Reports Disposal of Common Shares

Reuters
·
Jan 21

The Bull Case For United Therapeutics (UTHR) Could Change Following Phase 3 Ralinepag Trial Completion - Learn Why

Simply Wall St.
·
Jan 18

Assessing United Therapeutics (UTHR) Valuation After Recent Share Price Pullback

Simply Wall St.
·
Jan 17

United Therapeutics EVP & General Counsel Paul Mahon Reports Disposal of Common Shares

Reuters
·
Jan 16

Leerink Partners Reaffirms Their Buy Rating on United Therapeutics (UTHR)

TIPRANKS
·
Jan 14